Response to Interleukin-17A Inhibitors According to Prior Biologic Exposures: A Danish Nationwide Study

Whether response to an interleukin (IL-17) inhibitor is different in patients with previous exposure to an IL-17 inhibitor compared with patients with exposure to biologics with other cytokine targets remains to be elucidated. Therefore, the aim of this study was to assess whether previous exposure...

Descripción completa

Detalles Bibliográficos
Autores principales: LOFT, Nikolai, EGEBERG, Alexander, ISUFI, Daniel, RASMUSSEN, Mads K., BRYLD, Lars E., DAM, Tomas N., AJGEIY, Kawa K., BERTELSEN, Trine, SKOV, Lone
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medical Journals Sweden, on behalf of the Society for Publication of Acta Dermato-Venereologica 2023
Materias:
Original Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10680979/
https://www.ncbi.nlm.nih.gov/pubmed/37987625
http://dx.doi.org/10.2340/actadv.v103.12616

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10680979/
https://www.ncbi.nlm.nih.gov/pubmed/37987625
http://dx.doi.org/10.2340/actadv.v103.12616

Ejemplares similares